Most Popular
-
1
Now is no time to add pressure on businesses: top executives
-
2
CJ CheilJedang to spur overseas growth with new Hungary, US plants
-
3
Seoul to host winter festival from Dec. 13
-
4
Nationwide rail disruptions feared as union plans strike from Dec. 5
-
5
Blackpink's solo journeys: Complementary paths, not competition
-
6
N. Korea, Russia court softer image: From animal diplomacy to tourism
-
7
[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
-
8
Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid
-
9
Korean Air offers special flights for mileage users
-
10
Defense ministry denies special treatment for BTS’ V amid phone use allegations
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
Boyrung Biopharma launches 5-year cord blood research project
By Korea HeraldPublished : July 15, 2016 - 10:58
[THE INVESTOR] Boryung Biopharma is to research immune cell treatments using umbilical cord blood in collaboration with Seoul St. Mary’s Hospital.
The company said on July 14, that it signed an agreement with the hospital to conduct research in a 5-year project aimed at developing a range of treatments for immune cells.
By Choi He-suk (cheesuk@heraldcorp.com)
The company said on July 14, that it signed an agreement with the hospital to conduct research in a 5-year project aimed at developing a range of treatments for immune cells.
By Choi He-suk (cheesuk@heraldcorp.com)
-
Articles by Korea Herald
![[Today’s K-pop] Babymonster logs 100m views with ‘Drip’ music video](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/11/22/20241122050051_0.jpg&u=20241122172213)